Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin
Hien K Duong, Mikkael A SekeresCleveland Clinic Taussig Cancer Institute, Cleveland, Ohio USAAbstract: As the overall prognosis and treatment response rate to standard chemotherapy for acute myeloid leukemia (AML) remains poor in the older adult population, there is a need for more effective therape...
Guardado en:
Autores principales: | Hien K Duong, Mikkael A Sekeres |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa24b57d3e1c4bbea53e23c8d67b2dc7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey
por: Ayşe Hilal Eroğlu Küçükdiler, et al.
Publicado: (2021) -
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
por: Sonia Jaramillo, et al.
Publicado: (2021) -
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
por: Lim MY, et al.
Publicado: (2014) -
Suicide in older adults: current perspectives
por: Conejero I, et al.
Publicado: (2018) -
Polypharmacy in the HIV-infected older adult population
por: Gleason LJ, et al.
Publicado: (2013)